AbstractBackgroundAmong individuals with chronic heart failure with reduced ejection fraction (HFrEF), the predictive value for mortality by biomarker-based biological age (BA) and whether aerobic …
On this episode of The Deep Six Podcast, Dr. James Lewerenz and Dr. Joel Kahn spotlight the often-overlooked importance of heart health, urging early screeni…
The increasing use of immunotherapeutic approaches, cellular therapies, and targeted agents is rapidly and profoundly changing the treatment paradigms of haematological malignancies. These novel therapies…
The studies presented here are widely recognized for their robust methodologies and have significantly influenced our understanding of the relationship between
Compared with placebo, crizanlizumab has superior safety and comparable efficacy in patients with sickle cell disease.
ASCO 2025 study finds early palliative care doesn’t reduce healthcare use in new MM patients vs. standard care. Explore findings.
The Trump administration has canceled a contract awarded to Moderna for the late-stage development of its bird flu vaccine for humans, as well as the…
Stephen V. Liu, MD, discusses the most anticipated thoracic oncology data that will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting…
Achieving an optimal positioning of the digit during nail surgery is essential for surgical accuracy and patient safety. However, when performing the procedure without an…
AbstractBackgroundAlthough lipoprotein(a) (Lp[a]) has been associated with acute myocardial infarction (MI), the relationship between Lp(a) and the presence of high-risk “vulnerable” coronary plaqu…
